Rchr
J-GLOBAL ID：202301005077315292
Update date: Jul. 10, 2024
OIKE NAOKI
オオイケ ナオキ | OIKE NAOKI
Affiliation and department：
Job title：
Assistant professor
Research theme for competitive and other funds (1)：
- 2022 - 2024 Development of novel NK cell therapy for soft tissue sarcoma
Papers (18)：
-
Osamu Ansai, Ryota Hayashi, Anna Nakamura, Jin Sasaki, Akito Hasegawa, Tokiko Deguchi, Akihiko Yuki, Naoki Oike, Takashi Ariizumi, Masahiro Abe, et al. Deep dermatophytosis caused by Trichophyton rubrum in an elderly patient with CARD9 deficiency: A case report and literature review. The Journal of dermatology. 2024. 51. 2. 294-300
-
Yudai Murayama, Yasushi Kasahara, Nobuhiro Kubo, Chansu Shin, Masaru Imamura, Naoki Oike, Takashi Ariizumi, Akihiko Saitoh, Minori Baba, Tomohiro Miyazaki, et al. NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcoma. Translational oncology. 2022. 25. 101521-101521
-
Takashi Ariizumi, Hiroyuki Kawashima, Tetsuro Yamagishi, Naoki Oike, Yudai Murayama, Hajime Umezu, Naoto Endo, Akira Ogose. Diagnostic accuracy of fine needle aspiration cytology and core needle biopsy in bone and soft tissue tumor: A comparative study of the image-guided and blindly performed procedure. Annals of diagnostic pathology. 2022. 59. 151936-151936
-
Naoki Oike, Hiroyuki Kawashima, Akira Ogose, Hiroshi Hatano, Takashi Ariizumi, Tetsuro Yamagishi, Yudai Murayama, Hajime Umezu, Chihaya Imai, Masanori Hayashi, et al. Human leukocyte antigen I is significantly downregulated in patients with myxoid liposarcomas. Cancer immunology, immunotherapy : CII. 2021. 70. 12. 3489-3499
-
Yudai Murayama, Hiroyuki Kawashima, Nobuhiro Kubo, Chansu Shin, Yasushi Kasahara, Masaru Imamura, Naoki Oike, Takashi Ariizumi, Akihiko Saitoh, Keichiro Mihara, et al. Effectiveness of 4-1BB-costimulated HER2-targeted chimeric antigen receptor T cell therapy for synovial sarcoma. Translational oncology. 2021. 14. 12. 101227-101227
ｍore...
Professional career (1)：
- PH.D (Niigata University)
Awards (2)：
- 2022/06 - Yujin young Investigator Award
- 2019/12 - University of Colorado University of Colorado Postdoctoral Association Travelling Award High-throughput drug screening combined with a druggable target CRISPR drop-out screen identifies therapeutic vulnerabilities of BCOR-CCNB3 fusion positive sarcomas
Return to Previous Page
